Drawing for ZYREVLA

USPTO serial 88175267

ZYREVLA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BEDNARZ, DUSTIN THOMAS
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYREVLA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maren C. Perry

MAREN C. PERRY KING & SPALDING LLP1185 AVENUE OF THE AMERICASNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, sports injuries, namely, injured or torn skin, muscle, ligaments, or bone, cerebral palsy, muscle spasms, muscle tremors and pain; body creams, lotions and gels for medical purposes; eye creams, lotions and gels for medical purposesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 4, 2019MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Mar 4, 2019ABN5ABANDONMENT - AFTER PUBLICATION—
Feb 28, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Feb 25, 2019ALIEASSIGNED TO LIE—
Feb 7, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 7, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 7, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 7, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 7, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 5, 2019DOCKASSIGNED TO EXAMINER—
Nov 15, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance